English
简体中文
Total: £ 56.28
Published Date: 2024-12-04 | Pages: 113 | Tables: 183 | Medical Care
The global market for Peripheral Parenteral Nutrition (PPN) was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Peripheral Parenteral Nutrition (PPN) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Peripheral Parenteral Nutrition (PPN) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Peripheral Parenteral Nutrition (PPN) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Peripheral Parenteral Nutrition (PPN) include Eurofarma, Corporacion De Laboratorios Farmaceuticos, Baxter International Inc., Kelun Pharma, B. Braun, Fresenius, Teva Pharmaceutical Industries, Pfizer (Hospira) and Ostuka Pharmaceutical, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Peripheral Parenteral Nutrition (PPN), focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Peripheral Parenteral Nutrition (PPN) by region & country, by Type, and by Application.
The Peripheral Parenteral Nutrition (PPN) market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peripheral Parenteral Nutrition (PPN).
Market Segmentation
By Company
Eurofarma
Corporacion De Laboratorios Farmaceuticos
Baxter International Inc.
Kelun Pharma
B. Braun
Fresenius
Teva Pharmaceutical Industries
Pfizer (Hospira)
Ostuka Pharmaceutical
Laboratorios Biogalenic
Laboratorios Finlay
Grifols International
Fresenius Kabi
Sichuan Kelun Pharmaceutical
Segment by Type:
Carbohydrates
Parenteral Lipid Emulsion
Single Dose Amino Acid Solution
Trace Elements
Vitamins and Minerals
Segment by Application
Hospital
Home
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Peripheral Parenteral Nutrition (PPN) manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Peripheral Parenteral Nutrition (PPN) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Peripheral Parenteral Nutrition (PPN) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Peripheral Parenteral Nutrition (PPN) Product Introduction
1.2 Global Peripheral Parenteral Nutrition (PPN) Market Size Forecast
1.3 Peripheral Parenteral Nutrition (PPN) Market Trends & Drivers
1.3.1 Peripheral Parenteral Nutrition (PPN) Industry Trends
1.3.2 Peripheral Parenteral Nutrition (PPN) Market Drivers & Opportunity
1.3.3 Peripheral Parenteral Nutrition (PPN) Market Challenges
1.3.4 Peripheral Parenteral Nutrition (PPN) Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Peripheral Parenteral Nutrition (PPN) Players Revenue Ranking (2023)
2.2 Global Peripheral Parenteral Nutrition (PPN) Revenue by Company (2019-2024)
2.3 Key Companies Peripheral Parenteral Nutrition (PPN) Manufacturing Base Distribution and Headquarters
2.4 Key Companies Peripheral Parenteral Nutrition (PPN) Product Offered
2.5 Key Companies Time to Begin Mass Production of Peripheral Parenteral Nutrition (PPN)
2.6 Peripheral Parenteral Nutrition (PPN) Market Competitive Analysis
2.6.1 Peripheral Parenteral Nutrition (PPN) Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Peripheral Parenteral Nutrition (PPN) Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Parenteral Nutrition (PPN) as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Carbohydrates
3.1.2 Parenteral Lipid Emulsion
3.1.3 Single Dose Amino Acid Solution
3.1.4 Trace Elements
3.1.5 Vitamins and Minerals
3.2 Global Peripheral Parenteral Nutrition (PPN) Sales Value by Type
3.2.1 Global Peripheral Parenteral Nutrition (PPN) Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Peripheral Parenteral Nutrition (PPN) Sales Value, by Type (2019-2030)
3.2.3 Global Peripheral Parenteral Nutrition (PPN) Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Home
4.2 Global Peripheral Parenteral Nutrition (PPN) Sales Value by Application
4.2.1 Global Peripheral Parenteral Nutrition (PPN) Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Peripheral Parenteral Nutrition (PPN) Sales Value, by Application (2019-2030)
4.2.3 Global Peripheral Parenteral Nutrition (PPN) Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Peripheral Parenteral Nutrition (PPN) Sales Value by Region
5.1.1 Global Peripheral Parenteral Nutrition (PPN) Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Peripheral Parenteral Nutrition (PPN) Sales Value by Region (2019-2024)
5.1.3 Global Peripheral Parenteral Nutrition (PPN) Sales Value by Region (2025-2030)
5.1.4 Global Peripheral Parenteral Nutrition (PPN) Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Peripheral Parenteral Nutrition (PPN) Sales Value, 2019-2030
5.2.2 North America Peripheral Parenteral Nutrition (PPN) Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Peripheral Parenteral Nutrition (PPN) Sales Value, 2019-2030
5.3.2 Europe Peripheral Parenteral Nutrition (PPN) Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Peripheral Parenteral Nutrition (PPN) Sales Value, 2019-2030
5.4.2 Asia Pacific Peripheral Parenteral Nutrition (PPN) Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Peripheral Parenteral Nutrition (PPN) Sales Value, 2019-2030
5.5.2 South America Peripheral Parenteral Nutrition (PPN) Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Sales Value, 2019-2030
5.6.2 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Peripheral Parenteral Nutrition (PPN) Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Peripheral Parenteral Nutrition (PPN) Sales Value
6.3 United States
6.3.1 United States Peripheral Parenteral Nutrition (PPN) Sales Value, 2019-2030
6.3.2 United States Peripheral Parenteral Nutrition (PPN) Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Peripheral Parenteral Nutrition (PPN) Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Peripheral Parenteral Nutrition (PPN) Sales Value, 2019-2030
6.4.2 Europe Peripheral Parenteral Nutrition (PPN) Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Peripheral Parenteral Nutrition (PPN) Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Peripheral Parenteral Nutrition (PPN) Sales Value, 2019-2030
6.5.2 China Peripheral Parenteral Nutrition (PPN) Sales Value by Type (%), 2023 VS 2030
6.5.3 China Peripheral Parenteral Nutrition (PPN) Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Peripheral Parenteral Nutrition (PPN) Sales Value, 2019-2030
6.6.2 Japan Peripheral Parenteral Nutrition (PPN) Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Peripheral Parenteral Nutrition (PPN) Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Peripheral Parenteral Nutrition (PPN) Sales Value, 2019-2030
6.7.2 South Korea Peripheral Parenteral Nutrition (PPN) Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Peripheral Parenteral Nutrition (PPN) Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Peripheral Parenteral Nutrition (PPN) Sales Value, 2019-2030
6.8.2 Southeast Asia Peripheral Parenteral Nutrition (PPN) Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Peripheral Parenteral Nutrition (PPN) Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Peripheral Parenteral Nutrition (PPN) Sales Value, 2019-2030
6.9.2 India Peripheral Parenteral Nutrition (PPN) Sales Value by Type (%), 2023 VS 2030
6.9.3 India Peripheral Parenteral Nutrition (PPN) Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Eurofarma
7.1.1 Eurofarma Profile
7.1.2 Eurofarma Main Business
7.1.3 Eurofarma Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
7.1.4 Eurofarma Peripheral Parenteral Nutrition (PPN) Revenue (US$ Million) & (2019-2024)
7.1.5 Eurofarma Recent Developments
7.2 Corporacion De Laboratorios Farmaceuticos
7.2.1 Corporacion De Laboratorios Farmaceuticos Profile
7.2.2 Corporacion De Laboratorios Farmaceuticos Main Business
7.2.3 Corporacion De Laboratorios Farmaceuticos Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
7.2.4 Corporacion De Laboratorios Farmaceuticos Peripheral Parenteral Nutrition (PPN) Revenue (US$ Million) & (2019-2024)
7.2.5 Corporacion De Laboratorios Farmaceuticos Recent Developments
7.3 Baxter International Inc.
7.3.1 Baxter International Inc. Profile
7.3.2 Baxter International Inc. Main Business
7.3.3 Baxter International Inc. Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
7.3.4 Baxter International Inc. Peripheral Parenteral Nutrition (PPN) Revenue (US$ Million) & (2019-2024)
7.3.5 Kelun Pharma Recent Developments
7.4 Kelun Pharma
7.4.1 Kelun Pharma Profile
7.4.2 Kelun Pharma Main Business
7.4.3 Kelun Pharma Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
7.4.4 Kelun Pharma Peripheral Parenteral Nutrition (PPN) Revenue (US$ Million) & (2019-2024)
7.4.5 Kelun Pharma Recent Developments
7.5 B. Braun
7.5.1 B. Braun Profile
7.5.2 B. Braun Main Business
7.5.3 B. Braun Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
7.5.4 B. Braun Peripheral Parenteral Nutrition (PPN) Revenue (US$ Million) & (2019-2024)
7.5.5 B. Braun Recent Developments
7.6 Fresenius
7.6.1 Fresenius Profile
7.6.2 Fresenius Main Business
7.6.3 Fresenius Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
7.6.4 Fresenius Peripheral Parenteral Nutrition (PPN) Revenue (US$ Million) & (2019-2024)
7.6.5 Fresenius Recent Developments
7.7 Teva Pharmaceutical Industries
7.7.1 Teva Pharmaceutical Industries Profile
7.7.2 Teva Pharmaceutical Industries Main Business
7.7.3 Teva Pharmaceutical Industries Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
7.7.4 Teva Pharmaceutical Industries Peripheral Parenteral Nutrition (PPN) Revenue (US$ Million) & (2019-2024)
7.7.5 Teva Pharmaceutical Industries Recent Developments
7.8 Pfizer (Hospira)
7.8.1 Pfizer (Hospira) Profile
7.8.2 Pfizer (Hospira) Main Business
7.8.3 Pfizer (Hospira) Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
7.8.4 Pfizer (Hospira) Peripheral Parenteral Nutrition (PPN) Revenue (US$ Million) & (2019-2024)
7.8.5 Pfizer (Hospira) Recent Developments
7.9 Ostuka Pharmaceutical
7.9.1 Ostuka Pharmaceutical Profile
7.9.2 Ostuka Pharmaceutical Main Business
7.9.3 Ostuka Pharmaceutical Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
7.9.4 Ostuka Pharmaceutical Peripheral Parenteral Nutrition (PPN) Revenue (US$ Million) & (2019-2024)
7.9.5 Ostuka Pharmaceutical Recent Developments
7.10 Laboratorios Biogalenic
7.10.1 Laboratorios Biogalenic Profile
7.10.2 Laboratorios Biogalenic Main Business
7.10.3 Laboratorios Biogalenic Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
7.10.4 Laboratorios Biogalenic Peripheral Parenteral Nutrition (PPN) Revenue (US$ Million) & (2019-2024)
7.10.5 Laboratorios Biogalenic Recent Developments
7.11 Laboratorios Finlay
7.11.1 Laboratorios Finlay Profile
7.11.2 Laboratorios Finlay Main Business
7.11.3 Laboratorios Finlay Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
7.11.4 Laboratorios Finlay Peripheral Parenteral Nutrition (PPN) Revenue (US$ Million) & (2019-2024)
7.11.5 Laboratorios Finlay Recent Developments
7.12 Grifols International
7.12.1 Grifols International Profile
7.12.2 Grifols International Main Business
7.12.3 Grifols International Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
7.12.4 Grifols International Peripheral Parenteral Nutrition (PPN) Revenue (US$ Million) & (2019-2024)
7.12.5 Grifols International Recent Developments
7.13 Fresenius Kabi
7.13.1 Fresenius Kabi Profile
7.13.2 Fresenius Kabi Main Business
7.13.3 Fresenius Kabi Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
7.13.4 Fresenius Kabi Peripheral Parenteral Nutrition (PPN) Revenue (US$ Million) & (2019-2024)
7.13.5 Fresenius Kabi Recent Developments
7.14 Sichuan Kelun Pharmaceutical
7.14.1 Sichuan Kelun Pharmaceutical Profile
7.14.2 Sichuan Kelun Pharmaceutical Main Business
7.14.3 Sichuan Kelun Pharmaceutical Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
7.14.4 Sichuan Kelun Pharmaceutical Peripheral Parenteral Nutrition (PPN) Revenue (US$ Million) & (2019-2024)
7.14.5 Sichuan Kelun Pharmaceutical Recent Developments
8 Industry Chain Analysis
8.1 Peripheral Parenteral Nutrition (PPN) Industrial Chain
8.2 Peripheral Parenteral Nutrition (PPN) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Peripheral Parenteral Nutrition (PPN) Sales Model
8.5.2 Sales Channel
8.5.3 Peripheral Parenteral Nutrition (PPN) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Peripheral Parenteral Nutrition (PPN) Market Trends
Table 2. Peripheral Parenteral Nutrition (PPN) Market Drivers & Opportunity
Table 3. Peripheral Parenteral Nutrition (PPN) Market Challenges
Table 4. Peripheral Parenteral Nutrition (PPN) Market Restraints
Table 5. Global Peripheral Parenteral Nutrition (PPN) Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Peripheral Parenteral Nutrition (PPN) Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Peripheral Parenteral Nutrition (PPN) Product Type
Table 9. Key Companies Time to Begin Mass Production of Peripheral Parenteral Nutrition (PPN)
Table 10. Global Peripheral Parenteral Nutrition (PPN) Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Parenteral Nutrition (PPN) as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Peripheral Parenteral Nutrition (PPN) Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Peripheral Parenteral Nutrition (PPN) Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Peripheral Parenteral Nutrition (PPN) Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Peripheral Parenteral Nutrition (PPN) Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Peripheral Parenteral Nutrition (PPN) Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Peripheral Parenteral Nutrition (PPN) Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Peripheral Parenteral Nutrition (PPN) Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Peripheral Parenteral Nutrition (PPN) Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Peripheral Parenteral Nutrition (PPN) Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Peripheral Parenteral Nutrition (PPN) Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Peripheral Parenteral Nutrition (PPN) Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Peripheral Parenteral Nutrition (PPN) Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Peripheral Parenteral Nutrition (PPN) Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Peripheral Parenteral Nutrition (PPN) Sales Value by Region (2019-2024) & (%)
Table 27. Global Peripheral Parenteral Nutrition (PPN) Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Peripheral Parenteral Nutrition (PPN) Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Peripheral Parenteral Nutrition (PPN) Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Peripheral Parenteral Nutrition (PPN) Sales Value, (2025-2030) & (US$ Million)
Table 31. Eurofarma Basic Information List
Table 32. Eurofarma Description and Business Overview
Table 33. Eurofarma Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
Table 34. Revenue (US$ Million) in Peripheral Parenteral Nutrition (PPN) Business of Eurofarma (2019-2024)
Table 35. Eurofarma Recent Developments
Table 36. Corporacion De Laboratorios Farmaceuticos Basic Information List
Table 37. Corporacion De Laboratorios Farmaceuticos Description and Business Overview
Table 38. Corporacion De Laboratorios Farmaceuticos Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
Table 39. Revenue (US$ Million) in Peripheral Parenteral Nutrition (PPN) Business of Corporacion De Laboratorios Farmaceuticos (2019-2024)
Table 40. Corporacion De Laboratorios Farmaceuticos Recent Developments
Table 41. Baxter International Inc. Basic Information List
Table 42. Baxter International Inc. Description and Business Overview
Table 43. Baxter International Inc. Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
Table 44. Revenue (US$ Million) in Peripheral Parenteral Nutrition (PPN) Business of Baxter International Inc. (2019-2024)
Table 45. Baxter International Inc. Recent Developments
Table 46. Kelun Pharma Basic Information List
Table 47. Kelun Pharma Description and Business Overview
Table 48. Kelun Pharma Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
Table 49. Revenue (US$ Million) in Peripheral Parenteral Nutrition (PPN) Business of Kelun Pharma (2019-2024)
Table 50. Kelun Pharma Recent Developments
Table 51. B. Braun Basic Information List
Table 52. B. Braun Description and Business Overview
Table 53. B. Braun Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
Table 54. Revenue (US$ Million) in Peripheral Parenteral Nutrition (PPN) Business of B. Braun (2019-2024)
Table 55. B. Braun Recent Developments
Table 56. Fresenius Basic Information List
Table 57. Fresenius Description and Business Overview
Table 58. Fresenius Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
Table 59. Revenue (US$ Million) in Peripheral Parenteral Nutrition (PPN) Business of Fresenius (2019-2024)
Table 60. Fresenius Recent Developments
Table 61. Teva Pharmaceutical Industries Basic Information List
Table 62. Teva Pharmaceutical Industries Description and Business Overview
Table 63. Teva Pharmaceutical Industries Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
Table 64. Revenue (US$ Million) in Peripheral Parenteral Nutrition (PPN) Business of Teva Pharmaceutical Industries (2019-2024)
Table 65. Teva Pharmaceutical Industries Recent Developments
Table 66. Pfizer (Hospira) Basic Information List
Table 67. Pfizer (Hospira) Description and Business Overview
Table 68. Pfizer (Hospira) Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
Table 69. Revenue (US$ Million) in Peripheral Parenteral Nutrition (PPN) Business of Pfizer (Hospira) (2019-2024)
Table 70. Pfizer (Hospira) Recent Developments
Table 71. Ostuka Pharmaceutical Basic Information List
Table 72. Ostuka Pharmaceutical Description and Business Overview
Table 73. Ostuka Pharmaceutical Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
Table 74. Revenue (US$ Million) in Peripheral Parenteral Nutrition (PPN) Business of Ostuka Pharmaceutical (2019-2024)
Table 75. Ostuka Pharmaceutical Recent Developments
Table 76. Laboratorios Biogalenic Basic Information List
Table 77. Laboratorios Biogalenic Description and Business Overview
Table 78. Laboratorios Biogalenic Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
Table 79. Revenue (US$ Million) in Peripheral Parenteral Nutrition (PPN) Business of Laboratorios Biogalenic (2019-2024)
Table 80. Laboratorios Biogalenic Recent Developments
Table 81. Laboratorios Finlay Basic Information List
Table 82. Laboratorios Finlay Description and Business Overview
Table 83. Laboratorios Finlay Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
Table 84. Revenue (US$ Million) in Peripheral Parenteral Nutrition (PPN) Business of Laboratorios Finlay (2019-2024)
Table 85. Laboratorios Finlay Recent Developments
Table 86. Grifols International Basic Information List
Table 87. Grifols International Description and Business Overview
Table 88. Grifols International Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
Table 89. Revenue (US$ Million) in Peripheral Parenteral Nutrition (PPN) Business of Grifols International (2019-2024)
Table 90. Grifols International Recent Developments
Table 91. Fresenius Kabi Basic Information List
Table 92. Fresenius Kabi Description and Business Overview
Table 93. Fresenius Kabi Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
Table 94. Revenue (US$ Million) in Peripheral Parenteral Nutrition (PPN) Business of Fresenius Kabi (2019-2024)
Table 95. Fresenius Kabi Recent Developments
Table 96. Sichuan Kelun Pharmaceutical Basic Information List
Table 97. Sichuan Kelun Pharmaceutical Description and Business Overview
Table 98. Sichuan Kelun Pharmaceutical Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
Table 99. Revenue (US$ Million) in Peripheral Parenteral Nutrition (PPN) Business of Sichuan Kelun Pharmaceutical (2019-2024)
Table 100. Sichuan Kelun Pharmaceutical Recent Developments
Table 101. Key Raw Materials Lists
Table 102. Raw Materials Key Suppliers Lists
Table 103. Peripheral Parenteral Nutrition (PPN) Downstream Customers
Table 104. Peripheral Parenteral Nutrition (PPN) Distributors List
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
Table 108. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Peripheral Parenteral Nutrition (PPN) Product Picture
Figure 2. Global Peripheral Parenteral Nutrition (PPN) Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Peripheral Parenteral Nutrition (PPN) Sales Value (2019-2030) & (US$ Million)
Figure 4. Peripheral Parenteral Nutrition (PPN) Report Years Considered
Figure 5. Global Peripheral Parenteral Nutrition (PPN) Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Peripheral Parenteral Nutrition (PPN) Revenue in 2023
Figure 7. Peripheral Parenteral Nutrition (PPN) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Carbohydrates Picture
Figure 9. Parenteral Lipid Emulsion Picture
Figure 10. Single Dose Amino Acid Solution Picture
Figure 11. Trace Elements Picture
Figure 12. Vitamins and Minerals Picture
Figure 13. Global Peripheral Parenteral Nutrition (PPN) Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Peripheral Parenteral Nutrition (PPN) Sales Value Market Share by Type, 2023 & 2030
Figure 15. Product Picture of Hospital
Figure 16. Product Picture of Home
Figure 17. Global Peripheral Parenteral Nutrition (PPN) Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Peripheral Parenteral Nutrition (PPN) Sales Value Market Share by Application, 2023 & 2030
Figure 19. North America Peripheral Parenteral Nutrition (PPN) Sales Value (2019-2030) & (US$ Million)
Figure 20. North America Peripheral Parenteral Nutrition (PPN) Sales Value by Country (%), 2023 VS 2030
Figure 21. Europe Peripheral Parenteral Nutrition (PPN) Sales Value (2019-2030) & (US$ Million)
Figure 22. Europe Peripheral Parenteral Nutrition (PPN) Sales Value by Country (%), 2023 VS 2030
Figure 23. Asia Pacific Peripheral Parenteral Nutrition (PPN) Sales Value (2019-2030) & (US$ Million)
Figure 24. Asia Pacific Peripheral Parenteral Nutrition (PPN) Sales Value by Country (%), 2023 VS 2030
Figure 25. South America Peripheral Parenteral Nutrition (PPN) Sales Value (2019-2030) & (US$ Million)
Figure 26. South America Peripheral Parenteral Nutrition (PPN) Sales Value by Country (%), 2023 VS 2030
Figure 27. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Sales Value (2019-2030) & (US$ Million)
Figure 28. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Sales Value by Country (%), 2023 VS 2030
Figure 29. Key Countries/Regions Peripheral Parenteral Nutrition (PPN) Sales Value (%), (2019-2030)
Figure 30. United States Peripheral Parenteral Nutrition (PPN) Sales Value, (2019-2030) & (US$ Million)
Figure 31. United States Peripheral Parenteral Nutrition (PPN) Sales Value by Type (%), 2023 VS 2030
Figure 32. United States Peripheral Parenteral Nutrition (PPN) Sales Value by Application (%), 2023 VS 2030
Figure 33. Europe Peripheral Parenteral Nutrition (PPN) Sales Value, (2019-2030) & (US$ Million)
Figure 34. Europe Peripheral Parenteral Nutrition (PPN) Sales Value by Type (%), 2023 VS 2030
Figure 35. Europe Peripheral Parenteral Nutrition (PPN) Sales Value by Application (%), 2023 VS 2030
Figure 36. China Peripheral Parenteral Nutrition (PPN) Sales Value, (2019-2030) & (US$ Million)
Figure 37. China Peripheral Parenteral Nutrition (PPN) Sales Value by Type (%), 2023 VS 2030
Figure 38. China Peripheral Parenteral Nutrition (PPN) Sales Value by Application (%), 2023 VS 2030
Figure 39. Japan Peripheral Parenteral Nutrition (PPN) Sales Value, (2019-2030) & (US$ Million)
Figure 40. Japan Peripheral Parenteral Nutrition (PPN) Sales Value by Type (%), 2023 VS 2030
Figure 41. Japan Peripheral Parenteral Nutrition (PPN) Sales Value by Application (%), 2023 VS 2030
Figure 42. South Korea Peripheral Parenteral Nutrition (PPN) Sales Value, (2019-2030) & (US$ Million)
Figure 43. South Korea Peripheral Parenteral Nutrition (PPN) Sales Value by Type (%), 2023 VS 2030
Figure 44. South Korea Peripheral Parenteral Nutrition (PPN) Sales Value by Application (%), 2023 VS 2030
Figure 45. Southeast Asia Peripheral Parenteral Nutrition (PPN) Sales Value, (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Peripheral Parenteral Nutrition (PPN) Sales Value by Type (%), 2023 VS 2030
Figure 47. Southeast Asia Peripheral Parenteral Nutrition (PPN) Sales Value by Application (%), 2023 VS 2030
Figure 48. India Peripheral Parenteral Nutrition (PPN) Sales Value, (2019-2030) & (US$ Million)
Figure 49. India Peripheral Parenteral Nutrition (PPN) Sales Value by Type (%), 2023 VS 2030
Figure 50. India Peripheral Parenteral Nutrition (PPN) Sales Value by Application (%), 2023 VS 2030
Figure 51. Peripheral Parenteral Nutrition (PPN) Industrial Chain
Figure 52. Peripheral Parenteral Nutrition (PPN) Manufacturing Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
